MUTATION OF ASPARTATE RESIDUES IN THE 3RD EXTRACELLULAR LOOP OF THE RAT B-2 BRADYKININ RECEPTOR DECREASES AFFINITY FOR BRADYKININ

被引:37
作者
NOVOTNY, EA
BEDNAR, DL
CONNOLLY, MA
CONNOR, JR
STORMANN, TM
机构
[1] Scios Nova Inc., Department of Structural Biology, Baltimore
关键词
D O I
10.1006/bbrc.1994.1733
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two aspartates in the third extracellular loop of the rat B-2 bradykinin (BK) receptor have been implicated as important residues for agonist binding. Asp(268) and Asp(286) were mutated to alanine residues and changes in agonist and antagonist binding affinity were examined. The IC50 value for BK as a competitor of [H-3] NPC 17731 binding to the rat wild type receptor was 1.1 nM, while the Ala(268) and Ala(286) receptor mutants exhibited IC50 values of 19 nM and 28 nM, respectively. The Ala(268)Ala(286) receptor mutant exhibited an IC50 for BK of 500 nM. These mutations had little effect on binding affinity when NPC 17761, a BK antagonist, was used to compete [H-3] NPC 17731 binding. Electrophysiological examinationPof Xenopus oocytes expressing wild type or Ala(268)Ala(286) receptors confirmed the importance of the Asp(268) and Asp(286) residues for BK recognition. BK activated the mutant receptor with comparable efficacy relative to the wild type receptor, but a 1750-fold reduction in potency was observed. (C) 1994 Academic Press, Inc.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 32 条
  • [11] GAVRAS H, 1991, BRADYKININ ANTAGONIS, P171
  • [12] CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN BRADYKININ (BK-2) RECEPTOR
    HESS, JF
    BORKOWSKI, JA
    YOUNG, GS
    STRADER, CD
    RANSOM, RW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) : 260 - 268
  • [13] HILBERT MF, 1993, TRENDS PHARMACOL SCI, V14, P7
  • [14] HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x
  • [15] NMR AND COMPUTATIONAL EVIDENCE THAT HIGH-AFFINITY BRADYKININ RECEPTOR ANTAGONISTS ADOPT C-TERMINAL BETA-TURNS
    KYLE, DJ
    BLAKE, PR
    SMITHWICK, D
    GREEN, LM
    MARTIN, JA
    SINSKO, JA
    SUMMERS, MF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) : 1450 - 1460
  • [16] KYLE DJ, 1993, CURR OPIN INVEST DR, V2, P5
  • [17] KYLE DJ, 1991, BRADYKININ ANTAGONIS, P131
  • [18] PHARMACOLOGY OF KININS - THEIR RELEVANCE TO TISSUE-INJURY AND INFLAMMATION
    MARCEAU, F
    LUSSIER, A
    REGOLI, D
    GIROUD, JP
    [J]. GENERAL PHARMACOLOGY, 1983, 14 (02): : 209 - 229
  • [19] EXPRESSION CLONING OF A RAT B2-BRADYKININ RECEPTOR
    MCEACHERN, AE
    SHELTON, ER
    BHAKTA, S
    OBERNOLTE, R
    BACH, C
    ZUPPAN, P
    FUJISAKI, J
    ALDRICH, RW
    JARNAGIN, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7724 - 7728
  • [20] MUNOZ CM, 1992, J BIOL CHEM, V267, P303